Stock research log
$RAPP Insider Trading
Rapport Therapeutics, Inc.
7
Alerts Listed
7
Insider Buys 30d
0
Insider Sells 30d
This page is InsiderWatch’s research log for RAPP: the alerts we sent on this stock, timestamped, plus recent insider buying and selling reported to the SEC on Form 4.
Price and Our Alerts
$RAPP price
Daily closing prices
3M change
-46.3%
1Y high
$52.50
1Y low
$22.50
Our alerts
7
in this window
Prices from public market data and may be delayed. Markers show the days our alerts on this stock fired. Not investment advice.
Our Alerts on $RAPP
| Sent (ET) | Call | Alert |
|---|---|---|
| Oct 27, 4:57 PM | BEARISH | Rapport Therapeutics taps market after upbeat bipolar data |
| Oct 23, 4:01 PM | NEUTRAL | Rapport director joins insider buying with $98K stake |
| Oct 22, 4:58 PM | NEUTRAL | Fifth Rapport insider buy lifts cluster to $1.6M |
| Oct 22, 4:58 PM | NEUTRAL | Rapport director buys $974K as insiders pile in |
| Oct 22, 4:58 PM | NEUTRAL | Second Rapport director buys as insider cluster grows |
| Oct 22, 4:58 PM | NEUTRAL | Rapport director joins insider buying after 40% slide |
| Oct 21, 5:48 PM | NEUTRAL | Rapport Therapeutics CFO buys $144K of his own stock |
Every alert we sent on RAPP is listed after a short delay, in the order it went out. The call shown is the one in the alert as sent.
Recent Insider Activity
Open-market buys and sells in RAPP by the company’s own officers, directors, and large holders, as reported to the SEC on Form 4 in roughly the last 30 days. New to the filing? Read what a Form 4 is and what the transaction codes mean.
Daily buy vs sell dollars
Open-market insider filings that passed the significance gates, last 30 days
Bought
$22.0M
30 days
Sold
$0
30 days
Net flow
+$22.0M
buying leads
Active days
4
with gated filings
| Filed (ET) | Insider | Action | Value |
|---|---|---|---|
| Oct 30 | HEALY JAMESDirector | BUY | $20.4M |
| Oct 23 | Sanchez RamiroDirector | BUY | $98k |
| Oct 22 | Silva Paul MDirector | BUY | $100k |
| Oct 22 | Young Wendy B.Director | BUY | $100k |
| Oct 22 | PAUL STEVEN MDirector | BUY | $974k |
| Oct 22 | MARAGANORE JOHNDirector | BUY | $249k |
| Oct 21 | Ignelzi Troy A.Chief Financial Officer | BUY | $144k |
Sourced from public SEC Form 4 filings. Buys shown are open-market purchases; routine grants and plan sales are filtered out before a trade reaches this log.
See the research log across all stocks, this week’s insider buying, or the congress trading tracker.
Get the Next RAPP Alert When It Fires.
Everything here is already public. Subscribers usually got it within minutes. Pro members get every alert. Free for 7 days, cancel any time.
Try Free for 7 DaysInsiderWatch is an informational research service based on publicly available information only and is not financial, investment, legal, or tax advice. The call shown is a reading of the event, not a recommendation to trade.